publication date: May. 5, 2017
Faculty Senate Chair Julie Izzo: MD Anderson has evolved beyond “autocratic structure”
Chair, Faculty Senate
Associate professor in Translational Molecular Pathology, MD Anderson Cancer Center.
MD Anderson, through its Shared Governance Committee, is moving away from an “autocratic” structure, said Julie Izzo, chair of the Faculty Senate and an associate professor in Translational Molecular Pathology at MD Anderson Cancer Center.
Ronald DePinho, the fourth president of the Houston cancer hospital, resigned March 20 after leading the institution for over five years.
“You asked me what went wrong, and as I reflect, I think that culture matters. It matters a lot,” Izzo said to The Cancer Letter. “Over the past five years, we did have a clash of cultures, and it is important that there is an onboarding plan for the next president, and the onboarding plan must involve the MD Anderson community. That’s really necessary.”
Continue reading Faculty Senate Chair Julie Izzo: MD Anderson has evolved beyond “autocratic structure”
To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us
and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.